Corteva, Inc. $CTVA Shares Bought by Sanctuary Advisors LLC

Sanctuary Advisors LLC raised its position in Corteva, Inc. (NYSE:CTVA) by 8.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 83,529 shares of the company’s stock after buying an additional 6,454 shares during the quarter. Sanctuary Advisors LLC’s holdings in Corteva were worth $6,992,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of the company. JPL Wealth Management LLC acquired a new position in shares of Corteva in the 3rd quarter valued at $25,000. Garton & Associates Financial Advisors LLC acquired a new stake in Corteva during the 4th quarter worth $27,000. Bank of Jackson Hole Trust purchased a new position in Corteva during the 4th quarter worth $28,000. Cornerstone Financial Management LLC acquired a new position in Corteva in the fourth quarter valued at $29,000. Finally, Basepoint Wealth LLC acquired a new position in Corteva in the fourth quarter valued at $30,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Trading Up 0.9%

NYSE:CTVA opened at $87.42 on Friday. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $88.22. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The stock has a fifty day moving average price of $80.86 and a two-hundred day moving average price of $78.19. The stock has a market capitalization of $58.47 billion, a price-to-earnings ratio of 51.43, a PEG ratio of 2.67 and a beta of 0.56.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same period in the previous year, the firm earned $1.13 EPS. The business’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. Corteva’s dividend payout ratio (DPR) is 42.35%.

Analyst Ratings Changes

CTVA has been the subject of several recent research reports. Weiss Ratings upgraded shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. BNP Paribas Exane upped their price objective on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Rothschild & Co Redburn increased their price objective on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. The Goldman Sachs Group lifted their target price on Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, April 14th. Finally, CICC Research boosted their target price on Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, Corteva currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.95.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.